Key Takeaways
- Bitcoin surged approximately 5% to reach $71,418, propelling crypto-related equities higher: Strategy (+8%), Coinbase (+7%), and Riot Platforms (+4%)
- Moderna reached a $950M settlement in a patent dispute concerning its COVID-19 vaccine, a figure below market concerns
- Ross Stores exceeded Q4 projections and upgraded its outlook, with shares climbing as much as 7.5%
- GitLab declined roughly 9% following a Q4 earnings beat, due to disappointing full-year revenue projections
- Horizon Technology Finance tumbled 10% as total investment income of $20.7M fell short of the $23.9M forecast
Bitcoin experienced a significant rebound during Wednesday’s trading session, climbing approximately 5% to settle near $71,418. This upward momentum provided a boost to cryptocurrency-focused equities throughout the market.
Strategy advanced 8%, while Coinbase climbed roughly 7%, and MARA Holdings posted a 7% gain. Riot Platforms, Robinhood Markets, Galaxy Digital, and Hut 8 each registered increases ranging from 4% to 5%. Circle Internet Group also contributed with a 6% rise.
The cryptocurrency market’s resurgence followed a recent downturn linked to escalating geopolitical concerns in the Middle East. Market participants appeared to regain their appetite for risk assets as conditions showed signs of stabilization.
Precious metal mining companies also experienced gains during Wednesday’s session. Newmont advanced 2.8% while Freeport-McMoRan increased 1.9%, as Middle Eastern instability directed certain investors toward traditional safe-haven commodities like gold.
Moderna Resolves $950M Patent Litigation
Moderna finalized a $950 million settlement agreement with Arbutus Biopharma and Genevant Sciences. The litigation centered on intellectual property disputes involving its COVID-19 and RSV vaccine technologies.
Investors welcomed the settlement as favorable news, having anticipated a potentially larger financial obligation. Moderna’s COVID-19 vaccine franchise has produced between $45 billion and $50 billion in total revenue.
The settlement payment is scheduled for Q3 delivery and will be recognized as a first-quarter expense. Following this resolution, Moderna projects finishing the year with cash reserves between $4.5 billion and $5 billion.
Moderna plans to continue its appeal to the U.S. Federal Circuit. A positive outcome could eliminate any further payment obligations, though an unfavorable verdict might necessitate an additional $1.3 billion payment within a 90-day window.
Ross Stores delivered impressive performance, climbing up to 7.5% during premarket activity. The discount retailer surpassed Q4 earnings projections and provided guidance substantially exceeding analyst expectations for the upcoming quarter.
For the first quarter, Ross anticipates comparable sales expansion of 7% to 8%, contrasting with analyst projections of approximately 3.7%. The retailer also announced a 10% dividend increase.
GitLab and Horizon Decline on Cautious Forecasts
GitLab retreated between 8.5% and 9% notwithstanding a solid Q4 earnings performance. The software company’s annual revenue guidance range of $1.099 billion to $1.118 billion fell below the $1.13 billion consensus estimate.
CEO Bill Staples acknowledged dissatisfaction with the revenue outlook and presented five strategic initiatives designed to accelerate growth momentum.
Horizon Technology Finance plummeted 10% following a report showing total investment income of $20.7 million, missing the $23.9 million analyst estimate. The company’s net asset value per share also experienced a modest decline during the reporting period.
CrowdStrike ticked up 1.1% after surpassing Q4 earnings and revenue expectations. Box gained 6.2% following better-than-expected results and encouraging guidance for the present quarter.
Broadcom traded 1% higher in anticipation of its fiscal first-quarter earnings announcement scheduled for after market close, with analysts projecting its semiconductor division revenue will increase 51% compared to the prior year.
